Other highlights in the January 5 JNCI include a study that finds a growth factor, VEGFR-3, prevents lymphangiogenesis in a mouse model and may inhibit tumor metastasis, an examination of progesterone signaling and the risk of ovarian cancer, a study of dietary zinc, COX-2 expression, and esophageal and tongue carcinogenesis in rats, and an analysis of bone marker levels and the negative outcomes of bone metastases.

Read more...